Narcolepsy With Cataplexy
15
2
2
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 15 trials
100.0%
+13.4% vs benchmark
47%
7 trials in Phase 3/4
80%
8 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 10 completed trials
Clinical Trials (15)
Clarithromycin Mechanisms in Hypersomnia Syndromes
Decreasing Nightmares in Adults With Narcolepsy
A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy
Narcolepsy Nightmare Study
Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
Awareness and Self-Compassion Enhancing Narcolepsy Treatment
A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1
An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy
Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Xyrem and Brain Dopamine in Narcolepsy
A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy'
Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy
A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)